PHG — Koninklijke Philips NV Share Price
Last trade - 00:00- $25.13bn
- $30.97bn
- €17.83bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.54 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -11.64% | ||
| Dividend Yield (f) | 3.94% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.98 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 43.96 | ||
| Price to Sales | 1.22 | ||
| EV to EBITDA | 10.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.33% | ||
| Return on Equity | 7.83% | ||
| Operating Margin | 7.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 17,156 | 17,827 | 18,169 | 18,021 | 17,834 | 17,997.14 | 18,798.05 | 0.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.59 | -87.31 | +372.52 | +8.96 | +49.75 | -17.7 | +14.55 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Directors
- Feike Sijbesma CSU (62)
- Francois Van Houten CMG (60)
- Paulus Stoffels VSU (58)
- Abhijit Bhattacharya CFO (59)
- Sophie Bechu COO (61)
- Daniela Seabrook CHO (47)
- Marnix van Ginneken EVP (48)
- Robert Cascella EVP (67)
- Henk de Jong EVP (56)
- Andy Ho EVP (60)
- Roy Jakobs EVP (46)
- Deeptha Khanna EVP (44)
- Edwin Paalvast EVP (57)
- Vitor Rocha EVP (52)
- Jeroen Tas EVP (61)
- Bert Van Meurs EVP (59)
- Kees Wesdorp EVP (45)
- Neelam Dhawan IND (61)
- M. Elizabeth Doherty IND (63)
- A. Marc Harrison IND (56)
- Peter Loescher IND (63)
- David Pyott IND (68)
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- November 14th, 2000
- Public Since
- September 18th, 2009
- No. of Shareholders
- 731
- No. of Employees
- 64,817
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 951,288,934
- Address
- High Tech Campus 5, EINDHOVEN, 5656 AE
- Web
- https://www.philips.com/
- Phone
- +31 null205977777
- Contact
- Durga Doraisamy
- Auditors
- PricewaterhouseCoopers Accountants N.V
Latest News for PHG
Upcoming Events for PHG
Similar to PHG
Abbott Laboratories
New York Stock Exchange
Accendra Health
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
FAQ
As of Today at 20:37 UTC, shares in Koninklijke Philips NV are trading at $26.25. This share price information is delayed by 15 minutes.
Shares in Koninklijke Philips NV last closed at $26.25 and the price had moved by +1.43% over the past 365 days. In terms of relative price strength the Koninklijke Philips NV share price has underperformed the S&P500 Index by -11.65% over the past year.
The overall consensus recommendation for Koninklijke Philips NV is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreKoninklijke Philips NV does not currently pay a dividend.
Koninklijke Philips NV does not currently pay a dividend.
Koninklijke Philips NV does not currently pay a dividend.
To buy shares in Koninklijke Philips NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $26.25, shares in Koninklijke Philips NV had a market capitalisation of $25.13bn.
Here are the trading details for Koninklijke Philips NV:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: PHG
Based on an overall assessment of its quality, value and momentum Koninklijke Philips NV is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Koninklijke Philips NV is $33.00. That is 25.71% above the last closing price of $26.25.
Analysts covering Koninklijke Philips NV currently have a consensus Earnings Per Share (EPS) forecast of €1.51 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Koninklijke Philips NV. Over the past six months, its share price has underperformed the S&P500 Index by -3.86%.
As of the last closing price of $26.25, shares in Koninklijke Philips NV were trading -4.45% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Koninklijke Philips NV PE ratio based on its reported earnings over the past 12 months is 14.54. The shares last closed at $26.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Koninklijke Philips NV's management team is headed by:
- Feike Sijbesma - CSU
- Francois Van Houten - CMG
- Paulus Stoffels - VSU
- Abhijit Bhattacharya - CFO
- Sophie Bechu - COO
- Daniela Seabrook - CHO
- Marnix van Ginneken - EVP
- Robert Cascella - EVP
- Henk de Jong - EVP
- Andy Ho - EVP
- Roy Jakobs - EVP
- Deeptha Khanna - EVP
- Edwin Paalvast - EVP
- Vitor Rocha - EVP
- Jeroen Tas - EVP
- Bert Van Meurs - EVP
- Kees Wesdorp - EVP
- Neelam Dhawan - IND
- M. Elizabeth Doherty - IND
- A. Marc Harrison - IND
- Peter Loescher - IND
- David Pyott - IND